McLoughlin Margaret 4
4 · Quince Therapeutics, Inc. · Filed May 26, 2023
Insider Transaction Report
Form 4
McLoughlin Margaret
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-24+27,000→ 27,000 totalExercise: $1.58Exp: 2033-05-23→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of May 24, 2023.